Jerry Herron

719 total citations
20 papers, 573 citations indexed

About

Jerry Herron is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Jerry Herron has authored 20 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 6 papers in Immunology and Allergy. Recurrent topics in Jerry Herron's work include Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Pharmaceutical studies and practices (4 papers). Jerry Herron is often cited by papers focused on Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Pharmaceutical studies and practices (4 papers). Jerry Herron collaborates with scholars based in United States, Switzerland and United Kingdom. Jerry Herron's co-authors include Melton B. Affrime, Melvin D. Brannan, Christopher Banfield, Heribert Staudinger, Teddy Kosoglou, Desmond Padhi, Bhavna Kantesaria, C. Mohan Thonoor, R Stoltz and Angela Sansone‐Parsons and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and The American Journal of Cardiology.

In The Last Decade

Jerry Herron

20 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Herron United States 14 276 220 149 72 68 20 573
George Perentesis United States 9 90 0.3× 78 0.4× 40 0.3× 35 0.5× 13 0.2× 21 402
Mun Su Chung South Korea 16 92 0.3× 73 0.3× 201 1.3× 30 0.4× 11 0.2× 44 579
So-Hee Lee South Korea 14 179 0.6× 70 0.3× 137 0.9× 38 0.5× 16 0.2× 33 407
Bo Billing Sweden 12 182 0.7× 55 0.3× 221 1.5× 25 0.3× 19 0.3× 22 445
Jeremy Lyons United Kingdom 10 185 0.7× 19 0.1× 219 1.5× 152 2.1× 38 0.6× 11 616
Anne‐Sophie Archambault Canada 9 112 0.4× 20 0.1× 71 0.5× 26 0.4× 99 1.5× 12 392
Anne‐Marie Lorec France 11 175 0.6× 31 0.1× 54 0.4× 61 0.8× 3 0.0× 22 431
W A McAllister United Kingdom 8 111 0.4× 5 0.0× 154 1.0× 70 1.0× 58 0.9× 11 496
Eva Knuplez Austria 11 89 0.3× 22 0.1× 17 0.1× 48 0.7× 15 0.2× 14 395
Toshiyuki Suganuma Japan 12 33 0.1× 12 0.1× 116 0.8× 17 0.2× 23 0.3× 41 608

Countries citing papers authored by Jerry Herron

Since Specialization
Citations

This map shows the geographic impact of Jerry Herron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Herron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Herron more than expected).

Fields of papers citing papers by Jerry Herron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Herron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Herron. The network helps show where Jerry Herron may publish in the future.

Co-authorship network of co-authors of Jerry Herron

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Herron. A scholar is included among the top collaborators of Jerry Herron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Herron. Jerry Herron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kosoglou, Teddy, David L. Cutler, Heribert Staudinger, & Jerry Herron. (2009). Once-Daily Evening Dosing of Mometasone Furoate Administered via a Dry Powder Inhaler Does Not Adversely Affect the Hypothalamic-Pituitary-Adrenal Axis. CHEST Journal. 137(1). 115–121. 9 indexed citations
2.
He, Yanling, Ron Sabo, Franck Picard, et al.. (2009). Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes. Current Medical Research and Opinion. 25(5). 1265–1272. 32 indexed citations
3.
Kim, Kenneth, Ruediger Nave, Paul H. Ratner, et al.. (2007). Safety of Once-Daily Ciclesonide Nasal Spray in Children 2 to 5 Years of Age with Perennial Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 20(4). 229–242. 14 indexed citations
4.
Sansone‐Parsons, Angela, Gopal Krishna, Jason S. Simon, et al.. (2006). Effects of Age, Gender, and Race/Ethnicity on the Pharmacokinetics of Posaconazole in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 51(2). 495–502. 76 indexed citations
5.
Abdel‐Rahman, Susan M., et al.. (2005). Pharmacokinetics of Terbinafine in Young Children Treated for Tinea Capitis. The Pediatric Infectious Disease Journal. 24(10). 886–891. 19 indexed citations
6.
Staudinger, Heribert, et al.. (2004). Safety of desloratadine syrup in children. Current Medical Research and Opinion. 20(12). 1959–1965. 46 indexed citations
7.
Gupta, Samir K., et al.. (2004). Pharmacokinetics/Pharmacodynamics of Desloratadine and Fluoxetine in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(11). 1252–1259. 20 indexed citations
8.
Gupta, Samir K., Christopher Banfield, Melton B. Affrime, et al.. (2002). Desloratadine Demonstrates Dose Proportionality in Healthy Adults After Single Doses. Clinical Pharmacokinetics. 41(Supplement 1). 1–6. 21 indexed citations
9.
Banfield, Christopher, Jerry Herron, Anther Keung, Desmond Padhi, & Melton B. Affrime. (2002). Desloratadine Has No Clinically Relevant Electrocardiographic or Pharmacodynamic Interactions with Ketoconazole. Clinical Pharmacokinetics. 41(Supplement 1). 37–44. 42 indexed citations
10.
Affrime, Melton B., et al.. (2000). Mometasone Furoate Has Minimal Effects on the Hypothalamic-Pituitary-Adrenal Axis When Delivered at High Doses. CHEST Journal. 118(6). 1538–1546. 73 indexed citations
11.
Salmun, Luis M., Jerry Herron, Christopher Banfield, et al.. (2000). The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clinical Therapeutics. 22(5). 613–621. 35 indexed citations
12.
Herron, Jerry, et al.. (1998). Determination of the dose proportionality of single intravenous doses (5, 10, and 15 mg) of lubeluzole in healthy volunteers. Clinical Therapeutics. 20(4). 682–690. 3 indexed citations
13.
Zhou, Honghui, et al.. (1998). Pharmacokinetic profile of cisapride 20 mg after once- and twice-daily dosing. Clinical Therapeutics. 20(2). 292–298. 11 indexed citations
14.
Brannan, Melvin D., Jerry Herron, Pascale Reidenberg, & Melton B. Affrime. (1998). A Systemic Bioactivity Comparison of Double-Strength and Regular-Strength Beclomethasone Dipropionate MDI Formulations. Annals of Allergy Asthma & Immunology. 80(1). 39–44. 5 indexed citations
15.
Brannan, Melvin D., Jerry Herron, & Melton B. Affrime. (1997). Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clinical Therapeutics. 19(6). 1330–1339. 92 indexed citations
16.
Zhou, Honghui, et al.. (1997). A New Rapidly Disintegrating Formulation of Cisapride is Bioequivalent to Standard Cisapride Tablets in the Elderly. Clinical Drug Investigation. 14(6). 487–493. 3 indexed citations
17.
Brannan, Melvin D., Jerry Herron, Pascale Reidenberg, & Melton B. Affrime. (1995). Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Clinical Therapeutics. 17(4). 637–647. 35 indexed citations
18.
Pool, Peter E., Jerry Herron, Sidney Rosenblatt, et al.. (1989). Sustained‐Release Diltiazem: Duration of Antihypertensive Effect. The Journal of Clinical Pharmacology. 29(6). 533–537. 14 indexed citations
19.
Given, Bruce D., George Perentesis, Jerry Herron, et al.. (1989). Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations. The American Journal of Cardiology. 63(19). I12–I16. 6 indexed citations
20.
Pool, Peter E., Jerry Herron, Sidney Rosenblatt, et al.. (1988). Metabolic effects of antihypertensive therapy with a calcium antagonist. The American Journal of Cardiology. 62(11). 109–113. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Perentesis Breakdown of academic impact, for papers by Mun Su Chung Breakdown of academic impact, for papers by So-Hee Lee Breakdown of academic impact, for papers by Bo Billing Breakdown of academic impact, for papers by Jeremy Lyons Breakdown of academic impact, for papers by Anne‐Sophie Archambault Breakdown of academic impact, for papers by Anne‐Marie Lorec Breakdown of academic impact, for papers by W A McAllister Breakdown of academic impact, for papers by Eva Knuplez Breakdown of academic impact, for papers by Toshiyuki Suganuma
Rankless by CCL
2026